Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Comment by Mole101on Jun 16, 2021 1:38pm
174 Views
Post# 33395968

RE:New Board a must

RE:New Board a must

Elliot is gone already, he is just in a picture on the PMN website . If you notice no word from him in over half a year. ..Your wishful thinking it's not going to happen Goldtech. The board is set and they just need the stamp of approval, I already voted for all of them ...as RC posted before for some of us there has been a good profit over the last 4 years.

Not all the time but accumulation paid of expecially after the lows of .08 in December .. M101 she was here as many others ,  I'm sure they pull some profits and rebalanced their portfolios. Critizacing the board has become a sport over the years, but reality is you are doing your DD and making the decisions of staying invested here , regardless of DR Cashman who in my opinion has a lot to do with some of the choices made over the years, because they had opportunities to partner and part from some of their line of products and make some $$$,but he was likely the big NO in the group . He pulls a lot of money his way too, maybe is time for him to become more visible and engage on the PR side of things  too

quote=goldtech]I don't think the greedy duo that have done nothing but dilute the shares and took millions in their pockets will go away easily. Gene and Elliott talk a lot and produce nothing. Now I am withholding my votes on the proxy for everyone except Dr.Cashman and let's clean this inept board up and give it to the Boston group. We have a useless bunch on their now.[/quote]
 

<< Previous
Bullboard Posts
Next >>